Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation-Reference-Cited by-同舟云学术

Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation

Published:2015-09 Issue:6 Volume:59 Page:904-916
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

An Jian,Ren Shancheng,Murphy Stephen J.,Dalangood Sumiya,Chang Cunjie,Pang Xiaodong,Cui Yangyan,Wang Liguo,Pan Yunqian,Zhang Xiaowei,Zhu Yasheng,Wang Chenji,Halling Geoffrey C.,Cheng Liang,Sukov William R.,Karnes R. Jeffrey,Vasmatzis George,Zhang Qing,Zhang Jun,Cheville John C.,Yan Jun,Sun Yinghao,Huang Haojie

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference43 articles.

1. Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants;An;Cell Rep.,2014

2. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients;Baena;Genes Dev.,2013

3. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer;Barbieri;Nat. Genet.,2012

4. The genomic complexity of primary human prostate cancer;Berger;Nature,2011

5. SPOP mutations in prostate cancer across demographically diverse patient cohorts;Blattner;Neoplasia,2014

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KLHL20 and its role in cell homeostasis: A new perspective and therapeutic potential;Life Sciences;2024-09

2. Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer;Nature Communications;2024-08-05

3. Liquid–liquid phase separation in diseases;MedComm;2024-07

4. G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications;Cancers;2024-06-08

5. Molecular heterogeneity in prostate cancer and the role of targeted therapy;Life Sciences;2024-01